ARCHIVES

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala

June 18, 1993

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983